Skip to main content
. 2020 Sep 24;2(1):vdaa125. doi: 10.1093/noajnl/vdaa125

Table 3.

Adverse Events Upon Osimertinib 160 mg

Grades 1–2 Grade 3 Grades 4–5
Diarrhea 5/11 (45%) 0 0
Fatigue 3/11 (27%) 1/11 (9%) 0
Nail toxicity 2/11 (18%) 2/11 (18%) 0
Rash 3/11 (27%) 0 0
Dry skin 4/11 (36%) 0 0
Pruritus 3/11 (27%) 0 0
Headache 4/11 (36%) 0 0
Constipation 1/11 (9%) 0 0
Thrombocytopenia 2/11 (18%) 0 0
Decrease appetite 3/11 (27%) 0 0
Leukopenia 1/11 (9%) 0 0
Acne 1/11 (9%) 0 0